Experimental esophageal patch trial halted after just one patient
NCT ID NCT04689594
First seen Apr 02, 2026 · Last updated May 07, 2026 · Updated 5 times
Summary
This study tested a regenerative cell product placed on the wound after removing early-stage esophageal cancer. The goal was to prevent the esophagus from narrowing, a common complication. Only one person enrolled before the trial was stopped, so we have very little information about how well it works or its safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUPERFICIAL ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Okayama University Hospital
Okayama, 700-8558, Japan
Conditions
Explore the condition pages connected to this study.